From Tissue to Blood: How Liquid Biopsy is Transforming Precision Oncology in Asia

AGTC Genomics is proud to participate in the Next Generation Genomics Congress: Asia 2026, taking place on 31 March – 1 April 2026 at NIH, Malaysia.

🎤 Featured Talk:“From Tissue to Blood: How Liquid Biopsy is Transforming Precision Oncology in Asia”

As precision medicine continues to evolve, liquid biopsy is emerging as a powerful tool to complement—and in some cases redefine—traditional tissue-based diagnostics. This approach enables:

✔ Non-invasive cancer detection and monitoring

✔ Real-time insights into tumor dynamics

✔ Improved accessibility to genomic testing

✔ Better treatment stratification for patients

At AGTC Genomics, we are committed to advancing early detection, personalized treatment, and accessible genomics solutions across Asia, including innovations in liquid biopsy, MCED, and comprehensive gene profiling.

This congress provides an excellent platform to exchange ideas, foster collaborations, and accelerate the adoption of next-generation genomics in clinical practice.

📍 NIH, Malaysia

📅 31 March – 1 April 2026

We look forward to connecting with partners, clinicians, and researchers shaping the future of healthcare.